top of page
Buck-in-field_Web-Hero-Image
VMRD RT-QuIC for Chronic Wasting Disease
In partnership with CWD Evolution, ready-to-use RT-QuIC reagents are now available for detection of abnormal prions

RT-QuIC is a next generation testing technology that fundamentally alters the way we test for Chronic Wasting Disease (CWD). 


Similar to real-time PCR for bacteria and viruses, RT-QuIC detects abnormal prions through amplification and detection of fluorescent signal.

NEW PRODUCT ALERT!

RT-QuIC Synthetic Positive Control
(Catalog # RTQUIC-CWD-PC):

A novel and non-infectious synthetic positive control to support RT-QuIC testing

white check.png
white check.png
white check.png
white check.png
white check.png

Mimics activity of (+) RPLN

Non-infectious

Ready-to-use

Results in 24 hours

Early confirmation of test validity

NEW PRODUCT ALERT!

RT-QuIC Synthetic Positive Control
(Catalog # RTQUIC-CWD-PC):

A novel and non-infectious synthetic positive control to support RT-QuIC testing

white check.png
white check.png
white check.png
white check.png
white check.png

Mimics activity of (+) RPLN

Non-infectious

Ready-to-use

Results in 24 hours

Early confirmation of test validity

GRAPH - ACCURACY - GREEN.png

Standardized reagents for consistent results

Minimizes variability between individuals or labs

Little optimization required

READY-TO-USE---GREEN.png

Reagents are ready-to-use

No filtration or centrifugation required

Less handling leads to less opportunity for human error

Saves time

NO-CONVERSION---GREEN.png

Maximal sensitivity with minimal spontaneous protein conversion

Sensitive detection in many sample types

Reduces risk of false positives

obex-brainstem.png

Versatile and efficient

Can be used with many tissue types, including obex, lymph nodes, and rectal biopsies.

High-throughput – can be performed in 96- or 384-well plates.

Learn How to Perform the VMRD RT-QuIC Test

Testimonials

The value of using RT-QuIC reagents from VMRD is quality of the product and consistency of reagents while working to standardize protocols.  The VMRD suite of reagents provides that consistency not just with the substrate, but with the dilution and running buffers as well.  Additionally, the reagents are easy to use and do not require extra processing during the course of performing RT-QuIC beyond what might be required for prion purification or concentration of a specific sample source.

Michelle Lucey (Gibison), PhD

Michelle Lucey (Gibison), PhD

Senior Research Investigator @ University of Pennsylvania Wildlife Futures Program

Chronic Wasting Disease (CWD) is a rapidly spreading problem among wild and captive cervids. In the US, state and federal agencies are actively seeking ways to control this fatal disease.

RT-QuIC testing offers great potential to address key issues in CWD research and management:

Interested in learning more?
green check

EASIER SAMPLING PROCESS FOR HUNTERS

green check

LIVE ANIMAL TESTING USING RECTAL BIOPSIES (RAMALT)

green check

HIGH SENSITIVITY FOR EFFECTIVE POST-MORTEM TESTING & SURVEILLANCE

green check

EXPANDED INSIGHT INTO CWD GEOGRAPHICAL SPREAD & TRANSMISSION

green check

HIGH SENSITIVITY FOR EFFECTIVE POST-MORTEM TESTING & SURVEILLANCE

green check

EXPANDED INSIGHT INTO CWD GEOGRAPHICAL SPREAD & TRANSMISSION

green check

EASIER SAMPLING PROCESS FOR HUNTERS

green check

LIVE ANIMAL TESTING USING RECTAL BIOPSIES (RAMALT)

RT-QuIC Synthetic Positive Control

100 µL

RTQUIC-CWD-PC

Chronic Wasting Disease (CWD) 10X Sample Dilution Buffer

1 ml

RTQUIC-CWD-DB

Chronic Wasting Disease (CWD) 5X Reaction Buffer

1 ml

RTQUIC-CWD-RB

Chronic Wasting Disease (CWD) Amplification Reagent

1.25 ml

RTQUIC-CWD-AR

RT-QuIC Synthetic Positive Control

100 µL

RTQUIC-CWD-PC

Chronic Wasting Disease (CWD) 10X Sample Dilution Buffer

1 ml

RTQUIC-CWD-DB

Chronic Wasting Disease (CWD) 5X Reaction Buffer

1 ml

RTQUIC-CWD-RB

Chronic Wasting Disease (CWD) Amplification Reagent

1.25 ml

RTQUIC-CWD-AR

References

Cooper, Sarah K et al. “Detection of CWD in cervids by RT-QuIC assay of third eyelids.” PloS one vol. 14,8 e0221654. 28 Aug. 2019, doi:10.1371/journal.pone.0221654

Tewari, Deepanker et al. “Detection of chronic wasting disease in feces and recto-anal mucosal associated lymphoid tissues with RT-QuIC in a naturally infected farmed white-tailed deer herd.” Frontiers in veterinary science vol. 9 959555. 13 Sep. 2022, doi:10.3389/fvets.2022.959555>

Henderson, Davin M et al. “Progression of chronic wasting disease in white-tailed deer analyzed by serial biopsy RT-QuIC and immunohistochemistry.” PloS one vol. 15,2 e0228327. 14 Feb. 2020, doi:10.1371/journal.pone.0228327

Haley, N J et al. “Cross-validation of the RT-QuIC assay for the antemortem detection of chronic wasting disease in elk.” Prion vol. 14,1 (2020): 47-55. doi:10.1080/19336896.2020.1716657

Holz, Carine L et al. “Evaluation of Real-Time Quaking-Induced Conversion, ELISA, and Immunohistochemistry for Chronic Wasting Disease Diagnosis.” Frontiers in veterinary science vol. 8 824815. 18 Jan. 2022, doi:10.3389/fvets.2021.824815

Haley, Nicholas J et al. “Chronic wasting disease management in ranched elk using rectal biopsy testing.” Prion vol. 12,2 (2018): 93-108. doi:10.1080/19336896.2018.1436925

Hoover, Clare E et al. “Pathways of Prion Spread during Early Chronic Wasting Disease in Deer.” Journal of virology vol. 91,10 e00077-17. 28 Apr. 2017, doi:10.1128/JVI.00077-17

Haley, N J et al. “Management of chronic wasting disease in ranched elk: conclusions from a longitudinal three-year study.” Prion vol. 14,1 (2020): 76-87. doi:10.1080/19336896.2020.1724754

Haley, Nicholas J, and Jürgen A Richt. “Evolution of Diagnostic Tests for Chronic Wasting Disease, a Naturally Occurring Prion Disease of Cervids.” Pathogens (Basel, Switzerland) vol. 6,3 35. 5 Aug. 2017, doi:10.3390/pathogens6030035

bottom of page